Log In
BCIQ
Print this Print this
 

tretinoin (Vesanoid)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionOral formulation of a vitamin A derivative
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAcute promyelocytic leukemia (APL)
Indication DetailsTreat acute promyelocytic leukemia (APL)
Regulatory Designation
PartnerChugai Pharmaceutical Co. Ltd.;
Fuji Pharma Co. Ltd.;
Vitel Laboratorios S.A. de C.V.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/03/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today